Regulatory Reference This product is formulated to comply with USP compendial standards for sterile purified water and benzyl alcohol as a bacteriostatic preservative in multi-dose sterile preparations
Cardiovascular and metabolic diseases including obesity remain important areas of unmet medical need, and we plan to continue applying our global capabilities to advance a pipeline of investigational treatments that have the potential to fill critical gaps in patient care, including continued development of our oral GIPR antagonist candidate and other earlier obesity programs, said Chris Boshoff, MD, PhD, Chief Scientific Officer and President, Research and Development at Pfizer
Returns & Exchanges 1
There have been increased use and popularity by athletes, biohackers, and individuals with chronic injuries and chronic digestive issues due to its potential to shorten rehabilitation times
Our Approach to Treatment To minimize potential gastrointestinal side effects and help your body adjust, oral semaglutide is typically started at a low dose and gradually increased
